Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(33%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
1
33%
Ph phase_1
1
33%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
Phase 1Safety & dosage
1(50.0%)
N/ANon-phased studies
1(50.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(1)
Terminated(1)

Detailed Status

Active, not recruiting1
Completed1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (50.0%)
N/A1 (50.0%)

Trials by Status

active_not_recruiting133%
completed133%
withdrawn133%

Recent Activity

1 active trials
Showing 3 of 3
active_not_recruitingnot_applicable

Micro-Ultrasound for the Detection and Localization of Prostate Cancer Tumors in Patients Undergoing Radical Prostatectomy

NCT04299620
completed

Role of DIA in Diagnosing Nature of Indeterminate Biliary Duct Stricture

NCT04112030
withdrawnphase_1

Riluzole in Women With Stage I, Stage II, or Stage IIIA Breast Cancer

NCT00903214

Clinical Trials (3)

Showing 3 of 3 trials
NCT04299620Not Applicable

Micro-Ultrasound for the Detection and Localization of Prostate Cancer Tumors in Patients Undergoing Radical Prostatectomy

Active Not Recruiting
NCT04112030

Role of DIA in Diagnosing Nature of Indeterminate Biliary Duct Stricture

Completed
NCT00903214Phase 1

Riluzole in Women With Stage I, Stage II, or Stage IIIA Breast Cancer

Withdrawn

All 3 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
3